139 related articles for article (PubMed ID: 38764809)
41. Management and outcomes of patients for non-functioning pancreatic neuroendocrine tumours: a multi-institutional analysis.
Du B; Wang X; Zhang W; Tan Q; Wei Y; Shao Z
ANZ J Surg; 2022 Apr; 92(4):787-793. PubMed ID: 34723424
[TBL] [Abstract][Full Text] [Related]
42. High vimentin expression with E-cadherin expression loss predicts a poor prognosis after resection of grade 1 and 2 pancreatic neuroendocrine tumors.
Zhou B; Xiang J; Jin M; Zheng X; Li G; Yan S
BMC Cancer; 2021 Mar; 21(1):334. PubMed ID: 33789624
[TBL] [Abstract][Full Text] [Related]
43. Analysis of lymph node metastasis in pancreatic neuroendocrine tumors (PNETs) based on the tumor size and hormonal production.
Tsutsumi K; Ohtsuka T; Mori Y; Fujino M; Yasui T; Aishima S; Takahata S; Nakamura M; Ito T; Tanaka M
J Gastroenterol; 2012 Jun; 47(6):678-85. PubMed ID: 22350698
[TBL] [Abstract][Full Text] [Related]
44. Determinants of surgical resection for pancreatic neuroendocrine tumors.
Doi R
J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):610-7. PubMed ID: 25773163
[TBL] [Abstract][Full Text] [Related]
45. Surgical management of pancreatic neuroendocrine tumors: an introduction.
Hain E; Sindayigaya R; Fawaz J; Gharios J; Bouteloup G; Soyer P; Bertherat J; Prat F; Terris B; Coriat R; Gaujoux S
Expert Rev Anticancer Ther; 2019 Dec; 19(12):1089-1100. PubMed ID: 31825691
[No Abstract] [Full Text] [Related]
46. The Landmark Series: Pancreatic Neuroendocrine Tumors.
Cloyd JM; Poultsides GA
Ann Surg Oncol; 2021 Feb; 28(2):1039-1049. PubMed ID: 32948965
[TBL] [Abstract][Full Text] [Related]
47. Resection versus expectant management of small incidentally discovered nonfunctional pancreatic neuroendocrine tumors.
Rosenberg AM; Friedmann P; Del Rivero J; Libutti SK; Laird AM
Surgery; 2016 Jan; 159(1):302-9. PubMed ID: 26547726
[TBL] [Abstract][Full Text] [Related]
48. Operative resection in early stage pancreatic neuroendocrine tumors in the United States: Are we over- or undertreating patients?
Chivukula SV; Tierney JF; Hertl M; Poirier J; Keutgen XM
Surgery; 2020 Jan; 167(1):180-186. PubMed ID: 31537303
[TBL] [Abstract][Full Text] [Related]
49. Analysis of recurrence after resection of well-differentiated non-functioning pancreatic neuroendocrine tumors.
Tan QQ; Wang X; Yang L; Chen YH; Tan CL; Zhu XM; Ke NW; Liu XB
Medicine (Baltimore); 2020 Jun; 99(24):e20324. PubMed ID: 32541455
[TBL] [Abstract][Full Text] [Related]
50. Importance of lymph node involvement in pancreatic neuroendocrine tumors: impact on survival and implications for surgical resection.
Curran T; Pockaj BA; Gray RJ; Halfdanarson TR; Wasif N
J Gastrointest Surg; 2015 Jan; 19(1):152-60; discussion 160. PubMed ID: 25118642
[TBL] [Abstract][Full Text] [Related]
51. Impact and Clinical Predictors of Lymph Node Metastases in Nonfunctional Pancreatic Neuroendocrine Tumors.
Jiang Y; Jin JB; Zhan Q; Deng XX; Shen BY
Chin Med J (Engl); 2015 Dec; 128(24):3335-44. PubMed ID: 26668149
[TBL] [Abstract][Full Text] [Related]
52. Head and body/tail pancreatic neuroendocrine tumors have different biological characteristics and clinical outcomes.
Mei W; Ding Y; Wang S; Jia Y; Cao F; Li F
J Cancer Res Clin Oncol; 2020 Nov; 146(11):3049-3061. PubMed ID: 32601815
[TBL] [Abstract][Full Text] [Related]
53. Clinical significance of the preoperative main pancreatic duct dilation and neutrophil-to-lymphocyte ratio in pancreatic neuroendocrine tumors (PNETs) of the head after curative resection.
Zhou B; Zhan C; Xiang J; Ding Y; Yan S
BMC Endocr Disord; 2019 Nov; 19(1):123. PubMed ID: 31718651
[TBL] [Abstract][Full Text] [Related]
54. Venous invasion and lymphatic invasion are correlated with the postoperative prognosis of pancreatic neuroendocrine neoplasm.
Kiritani S; Arita J; Mihara Y; Nagata R; Ichida A; Kawaguchi Y; Ishizawa T; Akamatsu N; Kaneko J; Hasegawa K
Surgery; 2023 Feb; 173(2):365-372. PubMed ID: 36123176
[TBL] [Abstract][Full Text] [Related]
55. Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: Spectrum of imaging findings and pathological grading.
Hyodo R; Suzuki K; Ogawa H; Komada T; Naganawa S
Eur J Radiol; 2015 Nov; 84(11):2103-9. PubMed ID: 26321494
[TBL] [Abstract][Full Text] [Related]
56. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
[TBL] [Abstract][Full Text] [Related]
57. Comparison of prognosis between observation and surgical resection groups with small sporadic non-functional pancreatic neuroendocrine neoplasms without distant metastasis.
Kurita Y; Hara K; Kuwahara T; Mizuno N; Okuno N; Haba S; Okuno M; Natsume S; Senda Y; Kubota K; Nakajima A; Niwa Y; Shimizu Y
J Gastroenterol; 2020 May; 55(5):543-552. PubMed ID: 31858231
[TBL] [Abstract][Full Text] [Related]
58. Pancreatic neuroendocrine tumor: Correlations between MRI features, tumor biology, and clinical outcome after surgery.
Canellas R; Lo G; Bhowmik S; Ferrone C; Sahani D
J Magn Reson Imaging; 2018 Feb; 47(2):425-432. PubMed ID: 28480609
[TBL] [Abstract][Full Text] [Related]
59. Impact of tumor grade on pancreatic neuroendocrine tumors.
Shyr BS; Shyr BU; Chen SC; Shyr YM; Wang SE
Asian J Surg; 2022 Dec; 45(12):2659-2663. PubMed ID: 35246343
[TBL] [Abstract][Full Text] [Related]
60. When Should Lymphadenectomy Be Performed in Non-Metastatic Pancreatic Neuroendocrine Tumors? A Population-Based Analysis of the German Clinical Cancer Registry Group.
Abdalla TSA; Bolm L; Klinkhammer-Schalke M; Zeissig SR; Kleihues van Tol K; Bronsert P; Litkevych S; Honselmann KC; Braun R; Gebauer J; Hummel R; Keck T; Wellner UF; Deichmann S
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38275882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]